We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

subscriber-only content

LOG-IN

or

SUBSCRIBE NOW

for more website access

The content of this section is only available to Investors Chronicle online subscribers.

GW Pharma's sales evolve

Cannabis-based medicine group GW Pharmaceuticals reported solid progress, as the company rolled out its Sativex product for treating multiple sclerosis in Europe and Canada.

subscriber-only content

LOG-IN

or

SUBSCRIBE NOW

visible-status-Subscription-Only story-url-GW Pharma prelims 2011 221111.xml

By Julian Hofmann,
22 November 2011

Print this article Share this article

Comments

More tips and updates for this share

GW Pharma expects losses (GW Pharmaceuticals PLC) 28 November 2012 Tip Update
GW Pharma moving forward (GW Pharmaceuticals PLC) 22 May 2012 Tip update
GW Pharma gets cash boost (GW Pharmaceuticals PLC) 16 March 2012 Tip update
German approval for GW Pharma (GW Pharmaceuticals PLC) 01 June 2011 Tip update
GW Pharma progresses (GW Pharmaceuticals PLC) 18 May 2011 Tip update
GW Pharma hits Prague (GW Pharmaceuticals PLC) 19 April 2011 Tip update
Novartis deal boosts GW Pharma (GW Pharmaceuticals PLC) 11 April 2011 Tip update
GW Pharma eases pain in Spain (GW Pharmaceuticals PLC) 04 March 2011 Tip update
Tips of the year 2011 newspaper round-up (BHP Billiton PLC) 07 January 2011 Tip

Share Price

More by Julian Hofmann

IC columnists

Simon Thompson

Winning stock and trading ideas from the creator of the Bargain Portfolio

The Trader

Technical analysis and market calls from our in-house charting expert

Mr Bearbull

Sound advice on running portfolios from an experienced commentator

Smart Money

Practical advice and tips on planning your financial affairs

Chris Dillow

Incisive economic commentary plus thoughts on investor behaviour

Property Matters

Comment on the ups and downs of property investments, with a particular focus on the perennially popular world of buy to let

The Editor

Commentary on markets, world affairs and everything to do with investing

Chronic Investor Blog

Our light-hearted take on the world of investing

Advertiser reports

Register today and get...

Unlimited access to all of our non-premium articles
Full usage of our portfolio tools, alerts and data
Access to our Investment Guides
All the latest company news

Register today and get...

Register free now